Fasciola hepatica in Cattle and Sheep: Diagnostic Imaging and Liver Fluke Treatment Protocols

Introduction

Fasciola hepatica, the common liver fluke, is a trematode parasite of global distribution that causes significant economic losses in cattle and sheep through reduced productivity, liver condemnation, and mortality in acute cases [1, 2, 3]. The parasite requires an aquatic or amphibious lymnaeid snail as intermediate host, and its transmission is heavily influenced by climatic and hydrological factors [85, 162]. Infection leads to two distinct disease phenotypes: an acute, often fatal hepatitis in sheep due to massive parenchymal migration of immature flukes, and a chronic, more insidious cholangitis in cattle dominated by bile duct fibrosis and anaemia [25, 71]. These differing host responses drive divergent diagnostic and therapeutic strategies. This article provides an exhaustive review of diagnostic imaging modalities, coprological and serological techniques, and evidence-based treatment protocols, with emphasis on sustainable use of fasciolicides in the face of emerging anthelmintic resistance.

Diagnostic Approaches

Coprological Sedimentation Techniques

Detection of F. hepatica eggs in faeces remains the cornerstone of herd-level diagnosis. The gold standard is the sedimentation technique, which exploits the high specific gravity (approximately 1.20–1.25) of operculated eggs (130–150 µm × 63–90 µm). After homogenisation of 10–15 g of faeces with water and sequential sieving (425 µm and 150 µm), the sediment is examined microscopically [26, 56]. The Flukefinder method, a commercial sedimentation device, significantly improves egg recovery over simple sedimentation, with a reliable detection threshold of 5 eggs per gram (epg) in both sheep and cattle [26]. Composite faecal sampling (pooling 10 × 10 g samples from a herd) yields a diagnostic sensitivity of 0.69 for cattle, making it suitable for herd-level surveillance when individual sampling is impractical [56]. Standardisation of sedimentation protocols is critical because egg excretion is highly variable: cattle shed fewer eggs per gram than sheep relative to worm burden, necessitating larger sample volumes [46, 64].

Coproantigen ELISA

Enzyme-linked immunosorbent assays (ELISA) targeting F. hepatica excretory-secretory (ES) antigens in faeces provide earlier detection than coproscopy, as antigens are detectable from about 2–3 weeks post-infection, before patency (8–12 weeks) [44, 4]. The coproantigen ELISA (cELISA) utilises monoclonal or polyclonal antibodies against ES products, primarily cathepsin L proteases and glutathione S-transferase (GST) [5, 66]. The assay offers high specificity (greater than 95%) even in animals co-infected with gastrointestinal nematodes, coccidians, or rumen flukes (paramphistomes) [4, 6]. In diagnostic validation studies, the cELISA showed 100% sensitivity and 98.9% specificity in sheep, and 97.7% sensitivity and 97.7% specificity in cattle [66]. When used in parallel with faecal egg counts (FEC), cELISA significantly improves diagnostic sensitivity for epidemiological surveys [46]. The World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) recommends cELISA as a complementary tool for flukicide efficacy testing, with a second test at 6 weeks post-treatment improving reliability [52].

Serological Antibody Detection

Indirect ELISA for IgG antibodies against F. hepatica is widely used for herd screening, particularly in bulk tank milk for dairy cattle [1, 34]. Recombinant cathepsin L1 (FhCL-1) and saposin-like protein 2 (FhrSAP-2) are the most accurate antigens, with meta-analysed sensitivities of 0.931–0.985 and specificities of 0.959–0.997 across livestock species [7]. However, seropositivity indicates exposure only, not necessarily active infection, and antibodies persist for months after successful treatment [8, 77]. In naturally infected animals, the antibody response is broader and less specific to single antigens compared to experimental infections, cautioning against over-reliance on single-antigen tests for field diagnosis [8].

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting the ribosomal internal transcribed spacer (ITS-1, ITS-2) and mitochondrial cytochrome c oxidase subunit 1 (CO1) genes enable species differentiation between F. hepatica and F. gigantica, and detection of hybrids [9, 10, 68]. Nested PCR targeting ITS-2 can detect F. hepatica in liver tissue with 100% specificity [68]. Real-time PCR (qPCR) on faecal samples has a lower detection limit than conventional PCR (approximately 0.1 epg) and can detect infection as early as 1–2 weeks post-infection [44, 121]. Loop-mediated isothermal amplification (LAMP) and recombinase-aided amplification coupled with CRISPR/Cas12b (RAA-CRISPR) offer field-deployable, visual readout options for rapid detection in low-resource settings [89, 121]. High-resolution melting (HRM) analysis further enables simultaneous discrimination of F. hepatica and F. gigantica without sequencing [126].

Diagnostic Imaging

Diagnostic imaging is used primarily in individual animals with clinical signs of fasciolosis, especially acute hepatitis in sheep or chronic cholangitis in cattle. Transabdominal ultrasonography with a 3.5–5.0 MHz convex probe reveals characteristic lesions in the liver parenchyma and bile ducts. In acute fasciolosis, diffuse hypoechoic tracts representing necrotic migratory tunnels are visible. Chronic infection shows hyperechoic bile duct walls, ductal dilatation, and intraluminal echogenic material (inspissated bile, cellular debris, adult flukes) [91, 112]. Ultrasonography has moderate sensitivity (50–70%) for detecting adult flukes in bile ducts but is highly specific (greater than 90%) [112]. Magnetic resonance imaging, though rarely used in livestock due to cost, provides superior soft-tissue contrast, showing hypointense tracts on T1-weighted images and hyperintense lesions on T2-weighted sequences in hepatic parenchyma [112]. In the field, ultrasonography is a valuable adjunct to faecal diagnostics for confirming clinical cases and monitoring treatment response.

Comparison of Diagnostic Methods

The following table summarises the key performance parameters of principal diagnostic techniques for F. hepatica in cattle and sheep.

PI = post-infection. Data compiled from [26, 44, 46, 56, 66, 89, 112, 121].

Treatment Protocols

Fasciolicides: Mechanisms and Efficacy

Control of F. hepatica relies on a limited number of fasciolicides. The key compounds are triclabendazole (TCBZ), closantel, nitroxynil, clorsulon, albendazole, and rafoxanide [74, 90]. Their spectrum of activity against different fluke stages dictates treatment timing.

Triclabendazole is the only fasciolicide with high efficacy against both immature (2–8 weeks) and adult flukes, making it the drug of choice for acute fasciolosis and strategic treatments at housing or post-turnout [24, 49]. TCBZ is a benzimidazole derivative that binds to β-tubulin, inhibiting microtubule polymerisation and disrupting glucose uptake. Standard oral doses are 10 mg/kg in sheep and 12 mg/kg in cattle [70, 73]. Efficacy in field trials ranges from 83–100% against adult flukes [49, 70].

Closantel is a salicylanilide that uncouples oxidative phosphorylation in mitochondria, selectively affecting blood-feeding parasites due to its high protein binding. It is active against flukes older than 5 weeks and is therefore used for chronic fasciolosis [60, 90]. The recommended oral dose is 10 mg/kg in sheep and cattle [11].

Nitroxynil is a nitrophenol that also uncouples oxidative phosphorylation; it is effective against flukes older than 4 weeks at doses of 10 mg/kg (subcutaneous) in both species [48, 90].

Clorsulon is a sulfonamide that inhibits glycolysis; it is effective only against adult flukes (≥8 weeks) at 2–4 mg/kg oral or injectable [11, 48].

Albendazole has variable activity against adult flukes (40–90%) at 10 mg/kg, but is mainly used for gastrointestinal nematodes [48, 169].

Rafoxanide is a salicylanilide with activity against 6-week-old and adult flukes at 7.5–10 mg/kg [48, 90].

Anthelmintic Resistance

Resistance to TCBZ is now documented globally in both sheep and cattle, with reduced efficacy (less than 90% reduction in FEC or cELISA) reported in Europe, South America, and Australia [12, 31, 52, 73, 74]. The molecular mechanisms include polymorphisms in the β-tubulin isotype 3 gene (especially at codons 200 and 198), increased drug efflux via P-glycoprotein transporters, and enhanced drug metabolism [13, 27, 169]. Resistance to closantel and nitroxynil is less widespread but has been reported [74, 90]. In vitro egg hatch assays (EHA) using lethal dose 50 (LD50) calculations can detect resistance before treatment failure becomes evident in the field [90]. The W.A.A.V.P. guidelines for TCBZ resistance diagnosis recommend faecal egg count reduction tests (FECRT) and coproantigen reduction tests (CRT) at 14–21 days post-treatment (minimum 5 animals per group; per-protocol analysis) [52]. A reduction of less than 90% in arithmetic mean FEC or less than 50% reduction in CRT optical density is suggestive of resistance.

Strategic Treatment Protocols

Effective treatment requires integration of diagnostic surveillance, grazing management, and targeted treatments.

Acute fasciolosis (sheep) – TCBZ (10 mg/kg) is the only reliable option because immature flukes cause the pathology. Treatment must be applied at the first sign of an outbreak (e.g., sudden death, abdominal pain, anaemia). All animals at risk (e.g., those grazing high-risk pastures in wet seasons) should be dosed. A second dose 4–6 weeks later kills incoming fluke stages [86, 158].

Chronic fasciolosis (cattle and sheep) – Strategic treatments are timed to reduce pasture contamination. In temperate climates (e.g., UK, New Zealand, NW Europe), the standard strategy is:

• Winter housing / early spring: TCBZ (12 mg/kg cattle, 10 mg/kg sheep) to kill both adult flukes acquired in autumn/winter and early immature flukes.
• Mid-summer (July in N. Hemisphere): Closantel or nitroxynil to remove adult flukes and reduce egg output before new snail infections peak.
• Autumn (October): TCBZ again if risk remains high [81, 86].
• In tropical/subtropical regions (e.g., Andean highlands, parts of Africa), treatments should align with the beginning of the dry season when snail habitats shrink, using TCBZ or closantel [70, 117].

Resistance management – When resistance is confirmed, the following strategies are recommended:

• Switch to a non-benzimidazole fasciolicide (e.g., closantel, nitroxynil).
• Use combination products (e.g., TCBZ+ivermectin or closantel+abamectin) to target both nematodes and fluke, though this does not directly overcome TCBZ resistance [24, 52].
• Implement quarantine treatments for introduced animals using a drug with a different mode of action.
• Maintain refugia by leaving a proportion of animals untreated (if possible) to dilute resistant alleles, but this is risky in fasciolosis due to high pathogenicity [27].
• Rotate fasciolicides annually or biannually between salicylanilides (closantel, rafoxanide) and TCBZ.

No new fasciolicide classes have entered the market in the last two decades; therefore, preservation of existing molecules through diagnostic-informed, targeted treatments is paramount [74, 86].

Decision Tree for Diagnosis and Treatment

The Mermaid diagram below outlines a clinical decision algorithm for managing F. hepatica in sheep and cattle, integrating diagnostic steps and treatment choices.

flowchart TD
    A[Clinical suspicion: weight loss, anaemia, liver pathology], > B{Species?}
    B, >|Sheep acute| C[Acute death / abdomen pain / anaemia]
    B, >|Cattle chronic| D[Bottle jaw, poor production, liver condemnation]
    
    C, > E[Perform cELISA + qPCR (faeces)]
    E, > F{Positive?}
    F, >|Yes| G[Treat with TCBZ 10 mg/kg immediately]
    G, > H[Re-test FEC and cELISA at 14–21 d]
    H, > I{Reduction <90%?}
    I, >|Yes| J[Confirm resistance – switch to closantel 10 mg/kg]
    I, >|No| K[Successful treatment]
    
    D, > L[Herd-level screening: bulk tank milk ELISA or composite FEC]
    L, > M{Sero/coproprevalence >20%?}
    M, >|Yes| N[Implement strategic treatment: TCBZ at housing + closantel midsummer]
    M, >|No| O[Continue monitoring; treat only animals with individual FEC positive]
    
    N, > P{Resistance suspected?}
    P, >|Yes| Q[Perform FECRT or CRT with TCBZ]
    Q, > R{Reduction <90%?}
    R, >|Yes| S[Rotate to nitroxynil / rafoxanide; consider combination treatment]
    R, >|No| T[Maintain TCBZ as core drug]
    
    S, > U[Annual susceptibility testing via in vitro EHA]

Strategic Control and Future Directions

Sustainable control of fasciolosis requires an integrated approach combining diagnostic surveillance, targeted treatments, and environmental management. Grazing strategies such as draining wet pasture areas, rotating fields to break the snail-fluke life cycle, and avoiding grazing of high-risk pastures in spring/autumn reduce exposure [81, 138]. Biological control of intermediate lymnaeid snails (e.g., through competitive displacement or molluscicides) remains impractical at scale. Vaccines are under development: a Kunitz-type molecule (FhKT) formulated with CpG-ODN and lipid-based adjuvant achieved 81.6% reduction in faecal egg counts in sheep [14] and co-administration with cathepsin L5/B2 induced an anti-fecundity effect [69]. However, no commercial vaccine is yet available [140].

From a diagnostic perspective, point-of-care lateral flow tests (LFT) detecting anti-F. hepatica antibodies in whole blood now enable on-farm decision-making within 10 minutes, with field sensitivity of 67–96% and specificity of 71–80% depending on species [15]. This tool, when combined with cELISA, facilitates accurate assessment of flukicide efficacy [52].

Conclusion

Fasciola hepatica remains a major constraint to cattle and sheep production worldwide. The cornerstone of diagnosis remains composite coprological sedimentation and coproantigen ELISA, augmented by molecular methods for early detection and species identification. Diagnostic imaging with ultrasonography provides adjunctive value in clinical cases. Treatment protocols must be evidence-based, relying primarily on TCBZ for acute disease and strategic seasonal interventions for chronic infections. The global emergence of TCBZ resistance necessitates routine efficacy monitoring through FECRT and CRT, and judicious rotation of remaining fasciolicides. Integration of rapid on-farm diagnostics, responsible drug use, and environmental management offers the best pathway to sustainable control.

References

[1] Gröning H, Oksanen A, Skrzypczak T, et al. A survey for antibodies against Fasciola hepatica in cattle and sheep in Finland indicates a low level of exposure. Acta Vet Scand. 2023. URL: https://www.semanticscholar.org/paper/9d315ed7d5bb089d6ffdbf7a545543a311dbe0fa

[2] Delgado N, Pereira A, Martínez RA, et al. Seroprevalence and coprological prevalence of liver fluke Fasciola hepatica in cattle and sheep from Santander department, Colombia. Rev Bras Parasitol Vet. 2023. URL: https://www.semanticscholar.org/paper/bf1f527024791eb62997f20ee252a2a423fb88b3

[3] Pinilla J, Florez Muñoz AF, Uribe Delgado N. Prevalence and risk factors associated with liver fluke Fasciola hepatica in cattle and sheep in three municipalities in the Colombian Northeastern Mountains. Vet Parasitol Reg Stud Reports. 2020. URL: https://www.semanticscholar.org/paper/d78eeb9cc21e733067a9fe6cf5513f3998e76bec

[4] Kajugu P-E, Hanna R, Edgar H, et al. Fasciola hepatica: Specificity of a coproantigen ELISA test for diagnosis of fasciolosis in faecal samples from cattle and sheep concurrently infected with gastrointestinal nematodes, coccidians and/or rumen flukes (paramphistomes), under field conditions. Vet Parasitol. 2015. URL: https://www.semanticscholar.org/paper/50fda41acbaad8b57a6b3acd08eeae2f8b20efd9

[5] Duan J, Zhang N, Liu S, et al. The Detection of Circulating Antigen Glutathione S-Transferase in Sheep Infected with Fasciola hepatica with Double-Antibody Sandwich Signal Amplification Enzyme-Linked Immunosorbent Assay. Animals. 2024. URL: https://www.semanticscholar.org/paper/7f11f2109c680a1770812ca10e4295a48ca977ba

[6] Palmer D, Lyon J, Palmer M, et al. Evaluation of a cop

[7] Drescher G, Bello De Vasconcelos TC, Belo V, et al. Serological diagnosis of fasciolosis (Fasciola hepatica) in humans, cattle, and sheep: a meta-analysis. Front Vet Sci. 2023. URL: https://www.semanticscholar.org/paper/cdf2a867cd1052c0878b48b1f04f3fb722712b0a

[8] Walsh TR, Ainsworth S, Armstrong S, et al. Differences in the antibody response to adult Fasciola hepatica excretory/secretory products in experimentally and naturally infected cattle and sheep. Vet Parasitol. 2020. URL: https://www.semanticscholar.org/paper/cbacab4e5b0e158a8b08bb9d2b203d7be0f9ee55

[9] Halakou A, Taghipour N, Amin A, et al. Molecular Identification and Phylogenetic Analysis of Fasciola Hepatica Isolates From Cattle and Sheep in Golestan Province, Northeast of Iran. 2021. URL: https://www.semanticscholar.org/paper/a3d71be599d431c10d77490219c64c84bad35b49

[10] Uzun V, Çelik F, Şimşek S, et al. Multiplex PCR and Sequence Analysis to Investigate Genetic Diversity of Fasciola Isolates from Cattle and Sheep in Turkey. Pathogens. 2022. URL: https://www.semanticscholar.org/paper/78b56ab0d8f118986a8c495cd932d407608da688

[11] Zivmerman GL, Wallace D, Schons DJ, et al. Efficacy of clorsulon against mature, naturally acquired Fasciola hepatica infections in cattle and sheep. Am J Vet Res. 1986. URL: https://www.semanticscholar.org/paper/0f4322d754fc4ad4c17fc0bc12c136d5708e071d

[12] Moll L, Gaasenbeek C, Vellema P, et al. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The Netherlands. Vet Parasitol. 2000. URL: https://www.semanticscholar.org/paper/2f462597c276dc5942b75afaf44be79645bd5182

[13] Sadet Canakoglu S, Şimşek S, Balkaya I, et al. Preliminary Evidence for the Occurrence of β-tubulin Isotype 3 Polymorphisms in Fasciola Hepatica Isolates in Cattle and Sheep in Turkey. Helminthologia. 2019. URL: https://www.semanticscholar.org/paper/96b9f9e8683751942784cd3b1c0c827a9ab36fa5

[14] Ahumada M, Guasconi L, Maletto B, et al. Fasciola hepatica vaccine based on Kunitz-type molecule reduces adult worm fecundity in experimentally infected sheep. Vet Parasitol. 2025. URL: https://www.semanticscholar.org/paper/27e6320df4a67b3e5e4cfdaab1e7735d5a154c45

[15] Walsh TR, Angell JW, Bentham A, et al. Evaluation of a lateral flow test to diagnose liver fluke in cattle and sheep. Int J Parasitol. 2025. URL: https://www.semanticscholar.org/paper/f897e8d79e3d0ca1a4adafb59f27cbed2a385c0d

[16] DanielTicona S, Chávez V, Casas V, et al. Prevalence of Fasciola hepatica in cattle and sheep of Vilcashuaman, Ayacucho. 2010. URL: https://www.semanticscholar.org/paper/878cdb8e3c6a881bc6bb2bb75dca2b24d8c73caa

[17] Matoff K, Komandarev S. Epizootiological significance of intra-uterine infection with Fasciola hepatica in cattle and sheep. 1962. URL: https://www.semanticscholar.org/paper/70b4826003775d617cbc8964a11db349af3284ff

[18] Postevoy AN. Seasonal and Age Dynamics of Infection of Cattle and Sheep with Fasciola hepatica in the Territory of the Bryansk Region. Russian J Parasitol. 2019. URL: https://www.semanticscholar.org/paper/c52d23757cf72dc0bc328380a01eeefcd209aa68

[19] Vyas S, Mckay-Demeler J, Ward MP, et al. A contemporary map of Fasciola hepatica distribution in sheep and cattle in New South Wales. Aust Vet J. 2025. URL: https://www.semanticscholar.org/paper/41fcdf8ea7c2954e23677412760fc928524dad10

[20] Adili N, Oucheriah Y, Belabbas H. Prevalence of Fasciola Hepatica and Echinococcus Granulosus in slaughtered cattle, sheep, and goats in El-Hodna region (center of Algeria). Brazilian J Anim Environ Res. 2024. URL: https://www.semanticscholar.org/paper/1a1e3fad772a63f650c1d6e6ee0b17961eaa9571

[21] Bostelmann S, Luz E, Soccol V, et al. Hepatopathology of infection by Fasciola hepatica in cattle, buffaloes and sheep. 2000. URL: https://www.semanticscholar.org/paper/66a64314545b86cf4f5792fd0c7d8abc640aea1e

[22] Hanna R, Edgar H, Moffett D, et al. Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts. Vet Parasitol. 2008. URL: https://www.semanticscholar.org/paper/a94829ef909edca679f722d6645efd33e4ed474b

[23] Akça A, Gokce H, Mor N. Seroprevalence of Fasciola hepatica infection in cattle and sheep in the province of Kars, Turkey, as determined by ELISA. Helminthologia. 2014. URL: https://www.semanticscholar.org/paper/07b3cea4fe27f12c7c440c7783fbcbbae73c345b